Mesoblast | MSB - Net Income


Mesoblast reported $-17.34M in Net Income for its fiscal semester ending in June of 2026.





Net Income Change Date
Avita Medical AUD -11.62M 1.7M Dec/2025
Clinuvel Pharmaceuticals AUD 10.44M 11.65M Dec/2025
Cochlear AUD 161.5M 69.6M Dec/2025
CSL USD 401M 96.5M Dec/2025
Pacific Edge NZD -16.66M 2.45M Jun/2026
Paradigm Biopharmaceuticals AUD -23.24M 16.82M Dec/2025
PYC Therapeutics AUD -22.83M 10.46M Dec/2025
Ramsay Health Care AUD 152.7M 32.4M Dec/2025
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Starpharma Holdings AUD 1.37M 3.67M Dec/2025
Telix Pharmaceuticals AUD 38.33M 43.16M Jun/2026